Pasar al contenido principal

RESISTENCIA A LA INSULINA EN DIABETES TIPO 2: ESCLARECIENDO EL MECANISMO PATOGENICO ENTRE ORGANOS

PI20/01588

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Metabolic footprint of aging and obesity in red blood cells

  • Domingo-Ortí, Inés
  • Lamas-Domingo, Rubén
  • Hernández Pascual, Cristina
  • Herance Camacho, José Raul
  • Palomino-Schätzlein, Martina
  • Ciudin Mihai, Andreea
Aging; Metabolomics; Obesity, Envelliment; Metabolòmica; Obesitat, Envejecimiento; Metabolómica; Obesidad, Aging is a physiological process whose underlying mechanisms are still largely unknown. The study of the biochemical transformations associated with aging is crucial for understanding this process and could translate into an improvement of the quality of life of the aging population. Red blood cells (RBCs) are the most abundant cells in humans and are involved in essential functions that could undergo different alterations with age. The present study analyzed the metabolic alterations experienced by RBCs during aging, as well as the influence of obesity and gender in this process. To this end, the metabolic profile of 83 samples from healthy and obese patients was obtained by Nuclear Magnetic Resonance spectroscopy. Multivariate statistical analysis revealed differences between Age-1 (≤45) and Age-2 (>45) subgroups, as well as between BMI-1 (<30) and BMI-2 (≥30) subgroups, while no differences were associated with gender. A general decrease in the levels of amino acids was detected with age, in addition to metabolic alterations of glycolysis, the pentose phosphate pathway, nucleotide metabolism, glutathione metabolism and the Luebering-Rapoport shunt. Obesity also had an impact on the metabolomics profile of RBCs; sometimes mimicking the alterations induced by aging, while, in other cases, its influence was the opposite, suggesting these changes could counteract the adaptation of the organism to senescence., This work was supported by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064 and PI20/01588), the Agency for Management of University and Research Grants (AGAUR) of Catalonia (2017SGR1303) and the Ministry of Economy and Competitiveness (SAF2017-89229-R). Equipment employed in this work was partially funded by Generalitat Valenciana and ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Identification of Myocardial Insulin Resistance by Using Liver Tests: A Simple Approach for Clinical Practice

  • Herance Camacho, José Raul
  • Martin Saladich, Queralt
  • Velasquez Arevalo, Mayra Alejandra
  • Hernández Pascual, Cristina
  • Aparicio Gomez, Carolina
  • Ramírez Serra, Clara
  • Ferrer Costa, Roser
  • Pericàs Pulido, Juan Manuel
  • Castell Conesa, Joan
  • Aguade Bruix, Santiago
  • Simó Canonge, Rafael
  • Giralt Arnaiz, Marina
  • González Ballester, Miguel Ángel
Cardiovascular risk; Myocardial insulin resistance; Non-alcoholic fatty liver disease, Riesgo cardiovascular; Resistencia a la insulina del miocardio; Enfermedad del higado graso no alcoholico, Risc cardiovascular; Resistència a la insulina del miocardi; Malaltia del fetge gras no alcohòlic, Background: We report that myocardial insulin resistance (mIR) occurs in around 60% of patients with type 2 diabetes (T2D) and was associated with higher cardiovascular risk in comparison with patients with insulin-sensitive myocardium (mIS). These two phenotypes (mIR vs. mIS) can only be assessed using time-consuming and expensive methods. The aim of the present study is to search a simple and reliable surrogate to identify both phenotypes. Methods: Forty-seven patients with T2D underwent myocardial [18F]FDG PET/CT at baseline and after a hyperinsulinemic–euglycemic clamp (HEC) to determine mIR were prospectively recruited. Biochemical assessments were performed before and after the HEC. Baseline hepatic steatosis index and index of hepatic fibrosis (FIB-4) were calculated. Furthermore, liver stiffness measurement was performed using transient elastography. Results: The best model to predict the presence of mIR was the combination of transaminases, protein levels, FIB-4 score and HOMA (AUC = 0.95; sensibility: 0.81; specificity: 0.95). We observed significantly higher levels of fibrosis in patients with mIR than in those with mIS (p = 0.034). In addition, we found that patients with mIR presented a reduced glucose uptake by the liver in comparison with patients with mIS. Conclusions: The combination of HOMA, protein, transaminases and FIB-4 is a simple and reliable tool for identifying mIR in patients with T2D. This information will be useful to improve the stratification of cardiovascular risk in T2D., This work was supported by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064, PI20/01588) and the Agency for Management of University and Research Grants (AGAUR) of Catalonia (2017SGR1303).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Diabetic retinopathy features in lund MetS rats

  • Canz, María José
  • Baguña-Torres, Julia
  • Huerta, Jordi
  • Isla-Magrané, Helena
  • Zufiaurre Seijo, Maddalen
  • Salas Torras, Anna
  • Simó Canonge, Rafael
  • Garcia-Arumi, Jose
  • Herance, Jose Raul
  • Bogdanov, Patricia
  • Duarri, Anna
  • Hernandez, Cristina
Diabetic retinopathy; Metabolic syndrome; Neurodegeneration, Retinopatía diabética; Síndrome metabólico; Neurodegeneración, Retinopatia diabètica; Síndrome metabòlica; Neurodegeneració, The Lund MetS rat (BBDR.cg-Leprdb/db.cp/LundRj) is a novel animal model that has a congenic leptin receptor deficiency (LepR−/−) and males exhibit a variety of metabolic abnormalities mimicking the human metabolic syndrome, including hyperglycemia, dyslipidemia, severe obesity, and a type 2 diabetes-like condition from 14 weeks of age. However, whether Lund MetS rats (LM rats) develop diabetic retinopathy is still unknown. The purpose is to investigate the features of diabetic retinopathy in this model. In this study, male LM rats aged 15 and 30 weeks were analyzed for pathological retinal changes, including vasculopathy, inflammation, reactive gliosis, oxidative stress, and neurodegeneration features on the retinas by histological, immunohistochemical, and gene and protein expression analysis. Compared with the non-diabetic LM rats, diabetic LM rats, mainly at 30 weeks of age, had a decrease in retinal thickness and loss of retinal ganglion cells and photoreceptors, indicating retinal neurodegeneration. They also presented an increase in VEGF-A expression, Endra, Icam-1, Vcam-1, and Endrb vascular genes, and albumin suggesting neurovascular unit dysfunction. Furthermore, retinas presented reactive gliosis and infiltration of microglia, TNF-α-positive vessels and expressed elevated levels of inflammatory genes Tnf-α, IL-18 and IL-6, and oxidative stress markers Sod2 and 8-hydroxy-2-deoxyguanosine (8-OHdG). Our results suggest that diabetic LM rats reproduce the early neurodegenerative and altered neuro-vascular features that also occur in the human diabetic eye., This research project was funded by grants from Instituto de Salud Carlos III (PI20/01588 and PI22/01747), Agència Gestió Ajuts Universitaris i de Recerca (2017SGR1303), and Ministerio de Ciencia e Innovación, Gobierno de España (PID2022-138544OB-100 and PID2021-122807OB-C32).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on 18F-FDG PET/CT

  • Herance Camacho, José Raul
  • Velasquez Arevalo, Mayra Alejandra
  • Garcia León, Daniel
  • Aparicio Gomez, Carolina
  • Marès Pagès, Roso
  • Simó-Servat, Olga
  • Castell Conesa, Joan
  • Hernández Pascual, Cristina
  • Aguade Bruix, Santiago
  • Simó Canonge, Rafael
  • Paun, Bruno
Cardiovascular risk; Myocardial insulin resistance; Type 2 diabetes, Risc cardiovascular; Resistència miocàrdica a la insulina; Diabetis tipus 2, Riesgo cardiovascular; Resistencia miocárdica a la insulina; Diabetes tipo 2, Background: Systemic insulin resistance is generally postulated as an independent risk factor of cardiovascular events in type 2 diabetes (T2D). However, the role of myocardial insulin resistance (mIR) remains to be clarified. Methods: Two 18F-FDG PET/CT scans were performed on forty-three T2D patients at baseline and after hyperinsulinemic–euglycemic clamp (HEC). Myocardial insulin sensitivity (mIS) was determined by measuring the increment in myocardial 18F-FDG uptake after HEC. Coronary artery calcium scoring (CACs) and myocardial radiodensity (mRD) were assessed by CT. Results: After HEC, seventeen patients exhibited a strikingly enhancement of myocardial 18F-FDG uptake and twenty-six a marginal increase, thus revealing mIS and mIR, respectively. Patients with mIR showed higher mRD (HU: 38.95 [33.81–44.06] vs. 30.82 [21.48–38.02]; p = 0.03) and CACs > 400 (AU: 52% vs. 29%; p = 0.002) than patients with mIS. In addition, HOMA-IR and mIS only showed a correlation in those patients with mIR. Conclusions: 18F-FDG PET combined with HEC is a reliable method for identifying patients with mIR. This subgroup of patients was found to be specifically at high risk of developing cardiovascular events and showed myocardial structural changes. Moreover, the gold-standard HOMA-IR index was only associated with mIR in this subgroup of patients. Our results open up a new avenue for stratifying patients with cardiovascular risk in T2D., This research was funded by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064 and PI20/01588) and AGAUR (2017SGR1303 and 2017SGR1144).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences, A New Strategy Based on 18 F-FDG PET/CT

  • Herance, José Raul|||0000-0001-7178-3290
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Velasquez, Mayra Alejandra
  • Paun, Bruno
  • García Leon, Daniel|||0000-0001-7199-3079
  • Aparicio-Gómez, Carolina|||0000-0002-0845-2365
  • Marés, Roso|||0000-0002-7339-0172
  • Simó-Servat, Olga|||0000-0003-3483-652X
  • Castell-Conesa, Joan|||0000-0002-6449-9731
  • Hernández, Cristina|||0000-0002-3109-1721
  • Aguadé-Bruix, Santiago|||0000-0001-8617-6274
Background: Systemic insulin resistance is generally postulated as an independent risk factor of cardiovascular events in type 2 diabetes (T2D). However, the role of myocardial insulin resistance (mIR) remains to be clarified. Methods: Two 18 F-FDG PET/CT scans were performed on forty-three T2D patients at baseline and after hyperinsulinemic-euglycemic clamp (HEC). Myocardial insulin sensitivity (mIS) was determined by measuring the increment in myocardial 18 F-FDG uptake after HEC. Coronary artery calcium scoring (CACs) and myocardial radiodensity (mRD) were assessed by CT. Results: After HEC, seventeen patients exhibited a strikingly enhancement of myocardial 18 F-FDG uptake and twenty-six a marginal increase, thus revealing mIS and mIR, respectively. Patients with mIR showed higher mRD (HU: 38.95 [33.81-44.06] vs. 30.82 [21.48-38.02]; p = 0.03) and CACs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Footprint of Type 1 Diabetes on Red Blood Cells, A Metabolomic and Lipidomic Study

  • Herance, José Raul|||0000-0001-7178-3290
  • Ciudin, Andreea|||0000-0001-5622-0203
  • Lamas-Domingo, Rubén
  • Aparicio-Gómez, Carolina|||0000-0002-0845-2365
  • Hernández, Cristina|||0000-0002-3109-1721
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Palomino-Schätzlein, Martina
The prevalence of diabetes type 1 (T1D) in the world populations is continuously growing. Although treatment methods are improving, the diagnostic is still symptom-based and sometimes far after onset of the disease. In this context, the aim of the study was the search of new biomarkers of the disease in red blood cells (RBCs), until now unexplored. The metabolomic and the lipidomic profile of RBCs from T1D patients and matched healthy controls was determined by NMR spectroscopy, and different multivariate discrimination models were built to select the metabolites and lipids that change most significantly. Relevant metabolites were further confirmed by univariate statistical analysis. Robust separation in the metabolomic and lipidomic profiles of RBCs from patients and controls was confirmed by orthogonal projection on latent structure discriminant analysis (OPLS-DA), random forest analysis, and significance analysis of metabolites (SAM). The main changes were detected in the levels of amino acids, organic acids, creatine and phosphocreatine, lipid change length, and choline derivatives, demonstrating changes in glycolysis, BCAA metabolism, and phospholipid metabolism. Our study proves that robust differences exist in the metabolic and lipidomic profile of RBCs from T1D patients, in comparison with matched healthy individuals. Some changes were similar to alterations found already in RBCs of T2D patients, but others seemed to be specific for type 1 diabetes. Thus, many of the metabolic differences found could be biomarker candidates for an earlier diagnosis or monitoring of patients with T1D.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Insights into Insulin Resistance and Calcification in the Myocardium in Type 2 Diabetes, A Coronary Artery Analysis

  • Martín-Saladich, Queralt|||0000-0003-4798-1558
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Aguadé-Bruix, Santiago|||0000-0001-8617-6274
  • Simó-Servat, Olga|||0000-0003-3483-652X
  • Aparicio-Gómez, Carolina|||0000-0002-0845-2365
  • Hernández, Cristina|||0000-0002-3109-1721
  • Ramírez Serra, Clara|||0000-0001-8971-1711
  • Pizzi, María Nazarena|||0000-0001-5065-8546
  • Roque, Albert|||0000-0001-9738-3850
  • González Ballester, Miguel Ángel|||0000-0002-9227-6826
  • Herance, José Raul|||0000-0001-7178-3290
Type 2 diabetes (T2D) is responsible for high incidence of cardiovascular (CV) complications leading to heart failure. Coronary artery region-specific metabolic and structural assessment could provide deeper insight into the extent of the disease and help prevent adverse cardiac events. Therefore, in this study, we aimed at investigating such myocardial dynamics for the first time in insulin-sensitive (mIS) and insulin-resistant (mIR) T2D patients. We targeted global and region-specific variations using insulin sensitivity (IS) and coronary artery calcifications (CACs) as CV risk factor in T2D patients. IS was computed using myocardial segmentation approaches at both baseline and after an hyperglycemic-insulinemic clamp (HEC) on [ 18 F]FDG-PET images using the standardized uptake value (SUV) (ΔSUV = SUV - SUV) and calcifications using CT Calcium Scoring. Results suggest that some communicating pathways between response to insulin and calcification are present in the myocardium, whilst differences between coronary arteries were only observed in the mIS cohort. Risk indicators were mostly observed for mIR and highly calcified subjects, which supports previously stated findings that exhibit a distinguished exposure depending on the impairment of response to insulin, while projecting added potential complications due to arterial obstruction. Moreover, a pattern relating calcification and T2D phenotypes was observed suggesting the avoidance of insulin treatment in mIS but its endorsement in mIR subjects. The right coronary artery displayed more ΔSUV, whilst plaque was more present in the circumflex. However, differences between phenotypes, and therefore CV risk, were associated to left descending artery (LAD) translating into higher CACs regarding IR, which could explain why insulin treatment was effective for LAD at the expense of higher likelihood of plaque accumulation. Personalized approaches to assess T2D may lead to more efficient treatments and risk-prevention strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Myocardial Insulin Resistance by Using Liver Tests, A Simple Approach for Clinical Practice

  • Herance, José Raul|||0000-0001-7178-3290
  • Martín-Saladich, Queralt|||0000-0003-4798-1558
  • Velásquez, Mayra Alejandra
  • Hernández, Cristina|||0000-0002-3109-1721
  • Aparicio-Gómez, Carolina|||0000-0002-0845-2365
  • Ramírez Serra, Clara|||0000-0001-8971-1711
  • Ferrer Costa, Roser|||0000-0002-8925-3172
  • Giralt-Arnaiz, Marina
  • González Ballester, Miguel Ángel|||0000-0002-9227-6826
  • Pericàs, Juan M.|||0000-0002-3645-3293
  • Castell-Conesa, Joan|||0000-0002-6449-9731
  • Aguadé-Bruix, Santiago|||0000-0001-8617-6274
  • Simó Canonge, Rafael|||0000-0003-0475-3096
Background: We report that myocardial insulin resistance (mIR) occurs in around 60% of patients with type 2 diabetes (T2D) and was associated with higher cardiovascular risk in comparison with patients with insulin-sensitive myocardium (mIS). These two phenotypes (mIR vs. mIS) can only be assessed using time-consuming and expensive methods. The aim of the present study is to search a simple and reliable surrogate to identify both phenotypes. Methods: Forty-seven patients with T2D underwent myocardial [18F]FDG PET/CT at baseline and after a hyperinsulinemic-euglycemic clamp (HEC) to determine mIR were prospectively recruited. Biochemical assessments were performed before and after the HEC. Baseline hepatic steatosis index and index of hepatic fibrosis (FIB-4) were calculated. Furthermore, liver stiffness measurement was performed using transient elastography. Results: The best model to predict the presence of mIR was the combination of transaminases, protein levels, FIB-4 score and HOMA (AUC = 0.95; sensibility: 0.81; specificity: 0.95). We observed significantly higher levels of fibrosis in patients with mIR than in those with mIS (p = 0.034). In addition, we found that patients with mIR presented a reduced glucose uptake by the liver in comparison with patients with mIS. Conclusions: The combination of HOMA, protein, transaminases and FIB-4 is a simple and reliable tool for identifying mIR in patients with T2D. This information will be useful to improve the stratification of cardiovascular risk in T2D.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Diabetic retinopathy features in lund MetS rats

  • Canz, María José
  • Baguña-Torres, Julia
  • Huerta, Jordi
  • Isla-Magrané, Helena
  • Zufiaurre Seijo, Maddalen
  • Salas Torras, Anna
  • Simó Canonge, Rafael
  • Garcia-Arumi, Jose
  • Herance, Jose Raul
  • Bogdanov, Patricia
  • Duarri, Anna
  • Hernandez, Cristina
Diabetic retinopathy; Metabolic syndrome; Neurodegeneration, Retinopatía diabética; Síndrome metabólico; Neurodegeneración, Retinopatia diabètica; Síndrome metabòlica; Neurodegeneració, The Lund MetS rat (BBDR.cg-Leprdb/db.cp/LundRj) is a novel animal model that has a congenic leptin receptor deficiency (LepR−/−) and males exhibit a variety of metabolic abnormalities mimicking the human metabolic syndrome, including hyperglycemia, dyslipidemia, severe obesity, and a type 2 diabetes-like condition from 14 weeks of age. However, whether Lund MetS rats (LM rats) develop diabetic retinopathy is still unknown. The purpose is to investigate the features of diabetic retinopathy in this model. In this study, male LM rats aged 15 and 30 weeks were analyzed for pathological retinal changes, including vasculopathy, inflammation, reactive gliosis, oxidative stress, and neurodegeneration features on the retinas by histological, immunohistochemical, and gene and protein expression analysis. Compared with the non-diabetic LM rats, diabetic LM rats, mainly at 30 weeks of age, had a decrease in retinal thickness and loss of retinal ganglion cells and photoreceptors, indicating retinal neurodegeneration. They also presented an increase in VEGF-A expression, Endra, Icam-1, Vcam-1, and Endrb vascular genes, and albumin suggesting neurovascular unit dysfunction. Furthermore, retinas presented reactive gliosis and infiltration of microglia, TNF-α-positive vessels and expressed elevated levels of inflammatory genes Tnf-α, IL-18 and IL-6, and oxidative stress markers Sod2 and 8-hydroxy-2-deoxyguanosine (8-OHdG). Our results suggest that diabetic LM rats reproduce the early neurodegenerative and altered neuro-vascular features that also occur in the human diabetic eye., This research project was funded by grants from Instituto de Salud Carlos III (PI20/01588 and PI22/01747), Agència Gestió Ajuts Universitaris i de Recerca (2017SGR1303), and Ministerio de Ciencia e Innovación, Gobierno de España (PID2022-138544OB-100 and PID2021-122807OB-C32).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Identification of Myocardial Insulin Resistance by Using Liver Tests: A Simple Approach for Clinical Practice

  • Herance Camacho, José Raul
  • Martin Saladich, Queralt
  • Velasquez Arevalo, Mayra Alejandra
  • Hernández Pascual, Cristina
  • Aparicio Gomez, Carolina
  • Ramírez Serra, Clara
  • Ferrer Costa, Roser
  • Pericàs Pulido, Juan Manuel
  • Castell Conesa, Joan
  • Aguade Bruix, Santiago
  • Simó Canonge, Rafael
  • Giralt Arnaiz, Marina
  • González Ballester, Miguel Ángel
Cardiovascular risk; Myocardial insulin resistance; Non-alcoholic fatty liver disease, Riesgo cardiovascular; Resistencia a la insulina del miocardio; Enfermedad del higado graso no alcoholico, Risc cardiovascular; Resistència a la insulina del miocardi; Malaltia del fetge gras no alcohòlic, Background: We report that myocardial insulin resistance (mIR) occurs in around 60% of patients with type 2 diabetes (T2D) and was associated with higher cardiovascular risk in comparison with patients with insulin-sensitive myocardium (mIS). These two phenotypes (mIR vs. mIS) can only be assessed using time-consuming and expensive methods. The aim of the present study is to search a simple and reliable surrogate to identify both phenotypes. Methods: Forty-seven patients with T2D underwent myocardial [18F]FDG PET/CT at baseline and after a hyperinsulinemic–euglycemic clamp (HEC) to determine mIR were prospectively recruited. Biochemical assessments were performed before and after the HEC. Baseline hepatic steatosis index and index of hepatic fibrosis (FIB-4) were calculated. Furthermore, liver stiffness measurement was performed using transient elastography. Results: The best model to predict the presence of mIR was the combination of transaminases, protein levels, FIB-4 score and HOMA (AUC = 0.95; sensibility: 0.81; specificity: 0.95). We observed significantly higher levels of fibrosis in patients with mIR than in those with mIS (p = 0.034). In addition, we found that patients with mIR presented a reduced glucose uptake by the liver in comparison with patients with mIS. Conclusions: The combination of HOMA, protein, transaminases and FIB-4 is a simple and reliable tool for identifying mIR in patients with T2D. This information will be useful to improve the stratification of cardiovascular risk in T2D., This work was supported by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064, PI20/01588) and the Agency for Management of University and Research Grants (AGAUR) of Catalonia (2017SGR1303).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on 18F-FDG PET/CT

  • Herance Camacho, José Raul
  • Velasquez Arevalo, Mayra Alejandra
  • Garcia León, Daniel
  • Aparicio Gomez, Carolina
  • Marès Pagès, Roso
  • Simó Servat, Olga
  • Castell Conesa, Joan
  • Hernández Pascual, Cristina
  • Aguade Bruix, Santiago
  • Simó Canonge, Rafael
  • Paun, Bruno
Cardiovascular risk; Myocardial insulin resistance; Type 2 diabetes, Risc cardiovascular; Resistència miocàrdica a la insulina; Diabetis tipus 2, Riesgo cardiovascular; Resistencia miocárdica a la insulina; Diabetes tipo 2, Background: Systemic insulin resistance is generally postulated as an independent risk factor of cardiovascular events in type 2 diabetes (T2D). However, the role of myocardial insulin resistance (mIR) remains to be clarified. Methods: Two 18F-FDG PET/CT scans were performed on forty-three T2D patients at baseline and after hyperinsulinemic–euglycemic clamp (HEC). Myocardial insulin sensitivity (mIS) was determined by measuring the increment in myocardial 18F-FDG uptake after HEC. Coronary artery calcium scoring (CACs) and myocardial radiodensity (mRD) were assessed by CT. Results: After HEC, seventeen patients exhibited a strikingly enhancement of myocardial 18F-FDG uptake and twenty-six a marginal increase, thus revealing mIS and mIR, respectively. Patients with mIR showed higher mRD (HU: 38.95 [33.81–44.06] vs. 30.82 [21.48–38.02]; p = 0.03) and CACs > 400 (AU: 52% vs. 29%; p = 0.002) than patients with mIS. In addition, HOMA-IR and mIS only showed a correlation in those patients with mIR. Conclusions: 18F-FDG PET combined with HEC is a reliable method for identifying patients with mIR. This subgroup of patients was found to be specifically at high risk of developing cardiovascular events and showed myocardial structural changes. Moreover, the gold-standard HOMA-IR index was only associated with mIR in this subgroup of patients. Our results open up a new avenue for stratifying patients with cardiovascular risk in T2D., This research was funded by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064 and PI20/01588) and AGAUR (2017SGR1303 and 2017SGR1144).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Metabolic footprint of aging and obesity in red blood cells

  • Domingo-Ortí, Inés
  • Lamas-Domingo, Rubén
  • Hernández Pascual, Cristina
  • Herance Camacho, José Raul
  • Palomino-Schätzlein, Martina
  • Ciudin Mihai, Andreea
Aging; Metabolomics; Obesity, Envelliment; Metabolòmica; Obesitat, Envejecimiento; Metabolómica; Obesidad, Aging is a physiological process whose underlying mechanisms are still largely unknown. The study of the biochemical transformations associated with aging is crucial for understanding this process and could translate into an improvement of the quality of life of the aging population. Red blood cells (RBCs) are the most abundant cells in humans and are involved in essential functions that could undergo different alterations with age. The present study analyzed the metabolic alterations experienced by RBCs during aging, as well as the influence of obesity and gender in this process. To this end, the metabolic profile of 83 samples from healthy and obese patients was obtained by Nuclear Magnetic Resonance spectroscopy. Multivariate statistical analysis revealed differences between Age-1 (≤45) and Age-2 (>45) subgroups, as well as between BMI-1 (<30) and BMI-2 (≥30) subgroups, while no differences were associated with gender. A general decrease in the levels of amino acids was detected with age, in addition to metabolic alterations of glycolysis, the pentose phosphate pathway, nucleotide metabolism, glutathione metabolism and the Luebering-Rapoport shunt. Obesity also had an impact on the metabolomics profile of RBCs; sometimes mimicking the alterations induced by aging, while, in other cases, its influence was the opposite, suggesting these changes could counteract the adaptation of the organism to senescence., This work was supported by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064 and PI20/01588), the Agency for Management of University and Research Grants (AGAUR) of Catalonia (2017SGR1303) and the Ministry of Economy and Competitiveness (SAF2017-89229-R). Equipment employed in this work was partially funded by Generalitat Valenciana and ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020).